DMEMEDS shared post via Reuters: Former Merck dealmaker takes aim at colon germ

(Reuters) - An infectious disease expert and former head dealmaker at Merck & Co is racing against his ex-employer and other drugmakers to develop a treatment for a germ that ravages the colon and kills as many as 14,000 Americans each year. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/JAj-zvHLdSE/story01.htm

Read More